ADT: Assistive Device Training in Multiple Sclerosis

Sponsor
Portland VA Medical Center (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT02408718
Collaborator
Oregon Health and Science University (Other)
40
1
2
14.1
2.8

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether a training program in the use of ambulatory assistive devices (such as canes, walkers, etc) can reduce falls and increase functional mobility and neural connectivity in people with Multiple Sclerosis.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Assistive Device Training
N/A

Detailed Description

40 people with Multiple Sclerosis, who routinely use ambulatory assistive devices and have fallen at least once in the past year, will be randomized into two groups. One group will receive a 6-week training program in the use of their assistive device; the other group will be wait-listed, and may choose to receive the training after their participation in the study is completed. All participants will receive mobility assessments at baseline, 6-8 weeks later, and 3 months after that. All participants will record their falls on falls calendars. Participants in the training group will receive MRI scans to assess neural connectivity at baseline and after completion of the training program.

The purpose of the study is to determine whether participation in the training program reduces falls and increases functional mobility when compared to the wait-listed group, and also to determine whether any change in neural connectivity, as assessed by MRI scans, is seen in those who participate in the training.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Assistive Device Training for Functional Mobility and Connectivity in Multiple Sclerosis
Study Start Date :
Jul 1, 2015
Actual Primary Completion Date :
Sep 1, 2016
Actual Study Completion Date :
Sep 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Training group

Subjects randomized to this group will receive a 6 week Assistive Device Training program in the use of their assistive device. They will have mobility assessments taken at baseline, after the training program has been completed, and 3 months later. During this time, their falls will be recorded monthly using prospective falls calendars. Members of this group will also receive MRI scans at baseline and after the completion of the training program.

Behavioral: Assistive Device Training
Six-week training program on the proper use of the subject's assistive device (eg. cane, walker, etc).

No Intervention: Wait-list control

Subjects in this group will participate in the same mobility assessments and completion of the falls calendars, but will receive no intervention during this time. These subjects will have the opportunity to receive the training sessions when all assessment visits have been completed. These subjects will not receive MRI scans.

Outcome Measures

Primary Outcome Measures

  1. Change from Baseline in Functional Mobility at Completion of Training and the Following Three Months [At baseline, 1 week after completion of training, 3 months later]

    Timed Up and Go test, Timed 25-Foot Walk, 2 minute timed walk), Multiple Sclerosis Walking Scale-12

  2. Change from Baseline in Falls at Completion of Training and the Following Three Months [First week of training, last week of training, 3 months later]

    Change in rate of falls between time frames

  3. Change from Baseline in Functional Neural Connectivity (fMRI) at Completion of Training [At baseline, 1 week after completion of training]

    Resting-state (task free) functional Magnetic Resonance Imaging (fcMRI)

Secondary Outcome Measures

  1. Change from Baseline in Satisfaction with Assistive Device at Completion of Training and the Following Three Months [At baseline, 1 week after completion of training, 3 months later]

    Quebec User Evaluation of Satisfaction with Assistive Technologies

  2. Change from Baseline in Balance Confidence at Completion of Training and the Following Three Months [At baseline, 1 week after completion of training, 3 months later]

    Activities-specific Balance Confidence Questionnaire

  3. Change from Baseline in Multiple Sclerosis Impact at Completion of Training and the Following Three Months [At baseline, 1 week after completion of training, 3 months later]

    Multiple Sclerosis Impact Scale-29

  4. Change from Baseline in Physical Activity at Completion of Training and the Following Three Months [At baseline, 1 week after completion of training, 3 months later]

    International Physical Activity Questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Multiple Sclerosis of any type,

  • self-reported history of at least 1 fall in the previous year,

  • able to walk at least 25 feet with or without an assistive device,

  • clinically stable Multiple Sclerosis (no relapse in 30 days prior to enrollment),

  • intermittent or constant unilateral or bilateral assistance required to walk,

  • right-handed, willingness to remain consistent with medication use and level of physical activity for the duration of the study.

Exclusion Criteria:
  • serious psychiatric or medical conditions that would preclude reliable participation in the study,

  • dementia (MMSE <24),

  • deafness,

  • blindness,

  • inability to follow directions in English,

  • significant upper extremity tremor or weakness,

  • more than 1 hour of assistive device training within the previous 3 years,

  • any exclusions to receiving MRI scans (implanted devices, anxiety, claustrophobia, body weight over 350 lbs).

Contacts and Locations

Locations

Site City State Country Postal Code
1 VA Portland Health Care System Portland Oregon United States 97239

Sponsors and Collaborators

  • Portland VA Medical Center
  • Oregon Health and Science University

Investigators

  • Principal Investigator: Michelle H. Cameron, MD, PT MCR, Portland VA Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Michelle H. Cameron, MD, PT, MCR, Neurologist, Portland VA Medical Center
ClinicalTrials.gov Identifier:
NCT02408718
Other Study ID Numbers:
  • 3559
First Posted:
Apr 3, 2015
Last Update Posted:
Sep 21, 2016
Last Verified:
Apr 1, 2016
Keywords provided by Michelle H. Cameron, MD, PT, MCR, Neurologist, Portland VA Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 21, 2016